Related Experiment Video
Updated: Mar 6, 2026

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection
Published on: October 12, 2017
Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in
J Pelletier1, W Bruening, C E Kashtan
1Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, 02139.
Abstract:
Denys-Drash syndrome is a rare human condition in which severe urogenital aberrations result in renal failure, pseudohermaphroditism, and Wilms' tumor (nephroblastoma). To investigate its possible role, we have analyzed the coding exons of the Wilms' tumor suppressor gene (WT1) for germline mutations. In ten independent cases of Denys-Drash syndrome, point mutations in the zinc finger domains of one WT1 gene copy were found. Nine of these mutations are found within exon 9 (zinc finger III); the remaining mutation is in exon 8 (zinc finger II). These mutations directly affect DNA sequence recognition. In two families analyzed, the mutations were shown to arise de novo. Wilms' tumors from three individuals and one juvenile granulosa cell tumor demonstrate reduction to homozygosity for the mutated WT1 allele. Our results provide evidence of a direct role for WT1 in Denys-Drash syndrome and thus urogenital system development.
Insights
Denys-Drash syndrome, a condition causing kidney failure and pseudohermaphroditism, is linked to mutations in the Wilms' tumor suppressor gene (WT1). These WT1 gene mutations directly impact DNA recognition, affecting urogenital development.
Area of Science:
- Genetics
- Developmental Biology
- Oncology
Background:
- Denys-Drash syndrome is a rare disorder characterized by severe urogenital abnormalities, including renal failure, pseudohermaphroditism, and Wilms' tumor (nephroblastoma).
- The Wilms' tumor suppressor gene (WT1) plays a critical role in urogenital development and tumor suppression.
Purpose of the Study:
- To investigate the role of the Wilms' tumor suppressor gene (WT1) in the pathogenesis of Denys-Drash syndrome.
- To identify specific mutations within the WT1 gene associated with Denys-Drash syndrome.
Main Methods:
- Analysis of the coding exons of the WT1 gene for germline mutations in ten independent cases of Denys-Drash syndrome.
- Genomic analysis to identify mutations affecting DNA sequence recognition within the zinc finger domains of WT1.
- Investigation of allele status in tumor samples to assess for reduction to homozygosity.
Main Results:
- Point mutations were identified in the zinc finger domains of one WT1 gene copy in all ten Denys-Drash syndrome cases.
- Nine mutations were located in exon 9 (zinc finger III) and one in exon 8 (zinc finger II), directly impacting DNA sequence recognition.
- Tumor samples from affected individuals showed reduction to homozygosity for the mutated WT1 allele, suggesting its role as a tumor suppressor.
Conclusions:
- The findings provide direct evidence for a causal role of WT1 mutations in Denys-Drash syndrome.
- Mutations in WT1 are implicated in abnormal urogenital system development and the development of Wilms' tumors.
- WT1 mutations disrupt critical DNA recognition functions, leading to the complex phenotype of Denys-Drash syndrome.
More Related Videos
10:05Analysis of Zebrafish Kidney Development with Time-lapse Imaging Using a Dissecting Microscope Equipped for Optical Sectioning
Published on: April 7, 2016
10:51A Possible Zebrafish Model of Polycystic Kidney Disease: Knockdown of wnt5a Causes Cysts in Zebrafish Kidneys
Published on: December 2, 2014
Related Concept Videos
Canonical Wnt Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...